Study design

retrospective

Study time

2018.12-2019.12,2017.6-2018.11

Country

United States

Object

1. all men with localized prostate cancer who underwent RALRP with the da Vinci SP system at the Johns Hopkins Hospital from December 2018 to December 2019 by 3 attending urologists (MH, PMP, MEA) who all have extensive experience with RALRP using the standard multi-port robotic system. SP-RALRPs were performed using a transperitoneal approach with pelvic lymph node dissection (PLND) performed at the discretion of the attending surgeon. 2.The contemporaneous comparison cohort of men undergoing stan_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_dard RALRP for biopsy-confirmed, organ-confined prostate cance

Sample size

402

Topic classification

Focus on RARP

Keypoint

Based on an early experience with SP-RALRP at a high-volume center and a pooled alysis of SP series to date, perioperative and pathologic outcomes appear nearly equivalent compared to standard RALRP.

Year